Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
UNLABELLED: In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and sarcopenic obesity have been identified as adverse factors in cancer patients. Imaging quantification of body composition such as lean muscle mass and fat distribution is a potentially valuable tool. This review describes the following imaging techniques that may be used to assess body composition: dual-energy X-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI). CT and MRI are acquired as part of oncological patient care, thus providing an opportunity to integrate body composition assessment into the standard clinical pathway and allowing supportive care to be commenced as appropriate to improve outcome. MAIN MESSAGES: • Sarcopenia, sarcopenic obesity and visceral obesity are adverse prognostic factors in cancer patients. • CT and MRI are the current gold standard in body composition evaluation. • Body composition may affect chemotherapy tolerance and toxicities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In recent years, an increasing number of studies have focussed on body composition as a new and promising parameter for predicting prognosis in patients with malignancies [11][12][13].”
In the citing paper
“Decreased muscle density is an indicator for an increased lipid concentration in the skeletal muscle and is a known proxy for decreased muscle function [12].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767 · cited 3×
“Many proposed factors are involved in the development of cachexia such as chronic inflammation, increased muscle protein breakdown and insulin resistance [33, 37].”
BackgroundMethodEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 8×
“The DXA scan produces a two-dimensional image; therefore distinction between subcutaneous and visceral adipose tissue cannot be made.”
MethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 5×
“5 cm(2)/m(2) for males and females, respectively) to define sarcopenia have been proposed in cancer patients and were shown to be associated with mortality [1].”
BackgroundMethodInfluentialGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 1×
“Sarcopenia may be primary (age-related) or secondary (associated with reduced activity, poor nutrition, malabsorption, endocrine disease, neurodegenerative disorders or cancer cachexia) [28–31].”
BackgroundFox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882 · cited 1×
“Similarly, visceral adipose tissue as defined on CT has been shown to be associated with adverse cardiovascular risk factors [25].”
BackgroundMartin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680 · cited 1×
“Reduced skeletal muscle attenuation has also been found to be a negative prognostic factor in patients with gastrointestinal and respiratory tract cancers [67].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Many proposed factors are involved in the development of cachexia such as chronic inflammation, increased muscle protein breakdown and insulin resistance [33, 37].”
BackgroundMethodSimple proton spectroscopic imaging.
Dixon, W. T. (1984) · Radiology · doi:10.1148/radiology.153.1.6089263 · Cited by 2,276
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 11×
“The DXA scan produces a two-dimensional image; therefore distinction between subcutaneous and visceral adipose tissue cannot be made.”
BackgroundInfluentialMuscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732 · cited 4×
“assessment of muscle function, particularly in the diagnosis of sarcopenia [32].”
BackgroundMethodInfluentialShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“The L3 lumbar vertebra landmark is often used in crosssectional body composition analysis and is found to correspond to the whole-body tissue measurements [50, 53].”
BackgroundMitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522 · cited 1×
“The L3 lumbar vertebra landmark is often used in crosssectional body composition analysis and is found to correspond to the whole-body tissue measurements [50, 53].”
BackgroundLee, C. M. Y., Huxley, R. R., Wildman, R. P., & Woodward, M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.08.012 · Cited by 1,173 · cited 8×
“In the non-oncological setting, the waist circumference (WC) and waist-to-hip ratio (WHR) have been found to be better discriminators of diabetes and cardiovascular risks compared to BMI [12, 13].”
BackgroundInfluentialPapagiannopoulos, I. A., Sideris, V. I., Boschmann, M., Koutsoni, O. S., & Dotsika, E. N. (2013) · Complementary Medicine Research · doi:10.1159/000357718 · Cited by 1,128
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,104 · cited 3×
“toxicity and time to progression in patients with metastatic breast cancer treated with capecitabine [70].”
BackgroundSarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070 · cited 4×
“In addition, adipose tissue secretes pro-inflammatory cytokines and adipokines, promoting insulin resistance [34, 35], and these pro-inflammatory markers can contribute towards low muscle mass and obesity [36].”
BackgroundMethodInfluentialThe Metabolic Syndrome: A Global Public Health Problem and A New Definition
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., & Shaw, J. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.295 · Cited by 877 · cited 9×
“In the non-oncological setting, the waist circumference (WC) and waist-to-hip ratio (WHR) have been found to be better discriminators of diabetes and cardiovascular risks compared to BMI [12, 13].”
BackgroundInfluentialVisser, M., Kritchevsky, S. B., Goodpaster, B. H., Newman, A. B., Nevitt, M., Stamm, E., & Harris, T. B. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50217.x · Cited by 845 · cited 1×
“tially be a surrogate for muscle function [65, 66], with reduced HUwithin skeletal muscle representing increased intramuscular lipid deposition, which has been observed in those with neuromuscular disease [65].”
BackgroundLieffers, J. R., Bathe, O. F., Fassbender, K., Winget, M., & Baracos, V. E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.350 · Cited by 811 · cited 2×
“of adverse outcomes after primary colorectal surgery if they had co-existing sarcopenia [4].”
BackgroundHuxley, R., Mendis, S., Zheleznyakov, E., Reddy, S., & Chan, J. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.68 · Cited by 770 · cited 1×
“Anthropometric indices such as BMI, WC and WHR are associated with cardiovascular risk factors such as hypertension, diabetes and dyslipidemia, and cardiovascular disease [12, 72].”
BackgroundObesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715 · cited 1×
“The link between visceral obesity and adverse outcomes in cancer patients may be partly due to increased insulin resistance and its influence on levels of endocrine hormonal secretion, which is also associated cancer progression [26, 27].”
BackgroundThree‐point dixon technique for true water/fat decomposition with B0 inhomogeneity correction
Glover, G. H., & Schneider, E. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910180211 · Cited by 687 · cited 1×
“quence is used to correct for B0 field homogeneity [64].”
MethodSarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 653 · cited 2×
“These findings were confirmed in patients with advanced pancreatic cancer [48].”
BackgroundBody Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Mourtzakis, M., Mulder, K. E., Reiman, T., Butts, C. A., Scarfe, A. G., & Sawyer, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3067 · Cited by 619 · cited 4×
“The risk of toxicity is higher in female patients as they tend to have a lower lean bodymass in comparison to their body surface area [2].”
BackgroundInfluentialSarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“In addition, adipose tissue secretes pro-inflammatory cytokines and adipokines, promoting insulin resistance [34, 35], and these pro-inflammatory markers can contribute towards low muscle mass and obesity [36].”
BackgroundGriggs, J. J., Mangu, P. B., Anderson, H., Balaban, E. P., Dignam, J. J., Hryniuk, W. M., Morrison, V. A., Pini, T. M., Runowicz, C. D., Rosner, G. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.9436 · Cited by 485
Baracos, V. E., Reiman, T., Mourtzakis, M., Gioulbasanis, I., & Antoun, S. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608c · Cited by 482 · cited 1×
“CT and MRI are high spatial and contrast resolution crosssectional techniques that can provide estimates of lean muscle mass and adipose tissue as well as fat infiltration within the skeletal muscle [47–50].”
BackgroundSarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453 · cited 2×
“In addition, adipose tissue secretes pro-inflammatory cytokines and adipokines, promoting insulin resistance [34, 35], and these pro-inflammatory markers can contribute towards low muscle mass and obesity [36].”
BackgroundBody Composition Methods: Comparisons and Interpretation
Duren, D. L., Sherwood, R. J., Czerwinski, S. A., Lee, M., Choh, A. C., Siervogel, R. M., & Chumlea, W. C. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200623 · Cited by 451 · cited 1×
“As with any quantitative imaging technique, different manufacturers' software, calibration methods, calculation algorithms and scanners may result in variation in the calculated estimates of body composition [41, 43–46].”
MethodAntoun, S., Baracos, V. E., Birdsell, L., Escudier, B., & Sawyer, M. B. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp605 · Cited by 420 · cited 2×
“Similar observations were also noted in patients treatedwith sorafenib for metastatic renal cell carcinoma [3].”
BackgroundResultDual-energy X-ray absorptiometry and body composition
Laskey, M. A. (1996) · Nutrition · doi:10.1016/0899-9007(95)00017-8 · Cited by 407
Seidell, J., Bakker, C., & van der Kooy, K. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.953 · Cited by 375 · cited 1×
“These regions of interest are then further refined using specific Hounsfield unit (HU) segmentation thresholds in CT [1] or grey-level value thresholds in MRI, the latter requiring more complicated segmentation algorithms [51, 52].”
MethodAbate, N., Burns, D., Peshock, R. M., Garg, A., & Grundy, S. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40090-2 · Cited by 339
Pathophysiology and Pathogenesis of Visceral Fat Obesity
Matsuzawa, Y., Shimomura, I., Nakamura, T., Keno, Y., Kotani, K., & Tokunaga, K. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00462.x · Cited by 295
Aune, D., Navarro Rosenblatt, D. A., Chan, D. S. M., Vingeliene, S., Abar, L., Vieira, A. R., Greenwood, D. C., Bandera, E. V., & Norat, T. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv142 · Cited by 288 · cited 1×
“WHR have been found to be associated with increased risk of endometrial, oesophagogastric, colorectal and breast cancers [14–16] although conflicting results were obtained in prostate”
ResultClinical Applications of Body Composition Measurements Using DXA
Albanese, C. V., Diessel, E., & Genant, H. K. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:2:75 · Cited by 276 · cited 2×
“and bone mineral mass (BMM) [41], which can be extrapolated to the whole body (Fig.”
BackgroundMarked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Awad, S., Tan, B. H., Cui, H., Bhalla, A., Fearon, K. C. H., Parsons, S. L., Catton, J. A., & Lobo, D. N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.08.008 · Cited by 269 · cited 2×
“sarcopenic obesity increased following neoadjuvant chemotherapy in those with GOJ cancers [68].”
BackgroundResultBody composition: Why, when and for who?
Thibault, R., Genton, L., & Pichard, C. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.011 · Cited by 251 · cited 1×
“Body composition is an important feature in cancer patients as it may affect the efficacy and toxicity of chemotherapy, and it is associated with patient outcomes in terms of functional status, surgical complication rates, length of hospital stay (LOS) and overall survival (OS) [1–8].”
BackgroundStandardized assessment of whole body adipose tissue topography by MRI
Machann, J., Thamer, C., Schnoedt, B., Haap, M., Haring, H., Claussen, C. D., Stumvoll, M., Fritsche, A., & Schick, F. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20292 · Cited by 249
Otake, S., Takeda, H., Suzuki, Y., Fukui, T., Watanabe, S., Ishihama, K., Saito, T., Togashi, H., Nakamura, T., Matsuzawa, Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1868 · Cited by 231
Yip, C., Goh, V., Davies, A., Gossage, J., Mitchell-Hay, R., Hynes, O., Maisey, N., Ross, P., Gaya, A., Landau, D. B., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3110-4 · Cited by 223 · cited 1×
“the use of chemotherapy has been shown to alter body composition [69].”
BackgroundSelf-citationShepherd, J. A., Fan, B., Lu, Y., Wu, X. P., Wacker, W. K., Ergun, D. L., & Levine, M. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1654 · Cited by 218
Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
Tsujinaka, S., Konishi, F., Kawamura, Y. J., Saito, M., Tajima, N., Tanaka, O., & Lefor, A. T. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9395-0 · Cited by 213 · cited 1×
“Visceral obesity refers more specifically to the excessive accumulation of visceral fat in the abdominal cavity [10, 11, 19, 20].”
BackgroundHousel, E. L. (1949) · PubMed · Cited by 212
Body Composition Measured by Dual‐energy X‐ray Absorptiometry Half‐body Scans in Obese Adults
Rothney, M. P., Brychta, R. J., Schaefer, E. V., Chen, K. Y., & Skarulis, M. C. (2009) · Obesity · doi:10.1038/oby.2009.14 · Cited by 194
The evaluation of body composition: A useful tool for clinical practice
Thibault, R., & Pichard, C. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000334879 · Cited by 193 · cited 1×
“radiograph [56].”
Abate, N., Garg, A., Coleman, R., Grundy, S., & Peshock, R. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.403 · Cited by 185 · cited 1×
“Similar to CT, MRI evaluation at the level of the L2/3 vertebra was found to be a reliable estimate of fat mass [61].”
ResultVisceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer
Moon, H.-G., Ju, Y.-T., Jeong, C.-Y., Jung, E.-J., Lee, Y.-J., Hong, S.-C., Ha, W.-S., Park, S.-T., & Choi, S.-K. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9891-4 · Cited by 184
Visceral Fat Accumulation and Cardiovascular Disease
Matsuzawa, Y., Nakamura, T., Shimomura, I., & Kotani, K. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00481.x · Cited by 169
Visceral Obesity and Colorectal Cancer: Are We Missing the Boat with BMI?
Rickles, A. S., Iannuzzi, J. C., Mironov, O., Deeb, A., Sharma, A., Fleming, F. J., & Monson, J. R. T. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2045-9 · Cited by 166 · cited 2×
“However, associations between BMI and long-term outcomes and prognosis are weak in comparison to visceral obesity in cancer patients [5, 6, 10, 11].”
BackgroundClark, W., Siegel, E. M., Chen, Y. A., Zhao, X., Parsons, C. M., Hernandez, J. M., Weber, J., Thareja, S., Choi, J., & Shibata, D. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.01.007 · Cited by 154
Schreiner, P. J., Terry, J. G., Evans, G. W., Hinson, W. H., Crouse, J. R., & Heiss, G. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008934 · Cited by 144 · cited 1×
“5 cm(2) in females and males respectively [22].”
BackgroundTwo‐point Dixon technique for water‐fat signal decomposition with B0 inhomogeneity correction
Coombs, B. D., Szumowski, J., & Coshow, W. R. (1997) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910380606 · Cited by 141 · cited 1×
“3) [62, 63].”
Using two different algorithms to determine the prevalence of sarcopenia
Yoshida, D., Suzuki, T., Shimada, H., Park, H., Makizako, H., Doi, T., Anan, Y., Tsutsumimoto, K., Uemura, K., Ito, T., et al. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12210 · Cited by 140 · cited 2×
“The same group also defined the skeletal muscle mass index as appendicular skeletal mass/height(2) [40].”
BackgroundThe influences of height and age on waist circumference as an index of adiposity in adults
Han, T. S., Seidell, J. C., Currall, J., Morrison, C., Deurenberg, P., & Lean, M. E. J. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800371 · Cited by 132
Fowler, P., Fuller, M., Glasbey, C., Foster, M., Cameron, G., McNeill, G., & Maughan, R. J. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.1.18 · Cited by 117 · cited 1×
“The majority of the published literature on the use of MRI has evaluated its use in fat mass analysis [52, 58, 59].”
BackgroundSteffen, A., Huerta, J.-M., Weiderpass, E., Bueno-de-Mesquita, H. B., May, A. M., Siersema, P. D., Kaaks, R., Neamat-Allah, J., Pala, V., Panico, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29432 · Cited by 105 · cited 1×
“WHR have been found to be associated with increased risk of endometrial, oesophagogastric, colorectal and breast cancers [14–16] although conflicting results were obtained in prostate”
ResultNuclear magnetic resonance pulse sequence and discrimination of high- and low-fat tissues
Foster, M. A., Hutchison, J. M. S., Mallard, J. R., & Fuller, M. F. (1984) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(84)90004-3 · Cited by 84
Rapid Automated Measurement of Body Fat Distribution from Whole-Body MRI
Brennan, D. D., Whelan, P. F., Robinson, K. D., Ghita, O., O’Brien, J. M., Sadleir, R. J. T., & Eustace, S. J. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.185.2.01850418 · Cited by 80 · cited 3×
“These regions of interest are then further refined using specific Hounsfield unit (HU) segmentation thresholds in CT [1] or grey-level value thresholds in MRI, the latter requiring more complicated segmentation algorithms [51, 52].”
BackgroundMethodYoshida, D., Shimada, H., Park, H., Anan, Y., Ito, T., Harada, A., & Suzuki, T. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12177 · Cited by 76 · cited 1×
“881 (females) [39].”
Liu, M., Chino, N., & Ishihara, T. (1993) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/0003-9993(93)90115-q · Cited by 73 · cited 1×
“tially be a surrogate for muscle function [65, 66], with reduced HUwithin skeletal muscle representing increased intramuscular lipid deposition, which has been observed in those with neuromuscular disease [65].”
BackgroundHarding, J. L., Shaw, J. E., Anstey, K. J., Adams, R. J., Balkau, B., Brennan-Olsen, S. L., Briffa, T. G., Davis, T. M. E., Davis, W. A., Dobson, A. J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29529 · Cited by 72 · cited 2×
“WHR have been found to be associated with increased risk of endometrial, oesophagogastric, colorectal and breast cancers [14–16] although conflicting results were obtained in prostate”
ResultIntra-abdominal Fat Predicts Survival in Pancreatic Cancer
Balentine, C. J., Enriquez, J., Fisher, W. P., Hodges, S. E., Bansal, V., Sansgiry, S., Petersen, N. J., & Berger, D. H. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1297-5 · Cited by 71 · cited 1×
“Sarcopenic cancer patients have been shown to have higher rates of morbidity and mortality [1, 4, 6, 8, 10, 48].”
BackgroundTylavsky, F. A., Lohman, T. G., Dockrell, M., Lang, T., Schoeller, D. A., Wan, J. Y., Fuerst, T. P., Cauley, J. A., Nevitt, M. C., & Harris, T. B. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.356 · Cited by 65 · cited 1×
“As with any quantitative imaging technique, different manufacturers' software, calibration methods, calculation algorithms and scanners may result in variation in the calculated estimates of body composition [41, 43–46].”
MethodFedirko, V., Romieu, I., Aleksandrova, K., Pischon, T., Trichopoulos, D., Peeters, P. H. M., Romaguera, D., Bueno-de-Mesquita, H. B., Dahm, C. C., Overvad, K., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28841 · Cited by 61 · cited 1×
“There is a suggestion that WC and WHR are associated with inferior oncological outcomes such as colorectal cancer [18].”
BackgroundCoker, R. H., & Wolfe, R. R. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834da629 · Cited by 54 · cited 1×
“Sarcopenia may be primary (age-related) or secondary (associated with reduced activity, poor nutrition, malabsorption, endocrine disease, neurodegenerative disorders or cancer cachexia) [28–31].”
BackgroundCecchini, S., Cavazzini, E., Marchesi, F., Sarli, L., & Roncoroni, L. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0888-3 · Cited by 52
Validating Quantitative Obesity Measurements in Colorectal Cancer Patients
Balentine, C. J., Marshall, C. L., Robinson, C. N., Wilks, J. A., Anaya, D., Albo, D., & Berger, D. H. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.05.048 · Cited by 40 · cited 1×
“Thus, there are suggestions that visceral fat should be derived by obtaining measurements at several different anatomic levels [54] although others have found no significant clinical impact when correlating visceral fat measured at L2L3, L4-L5 and mid waist levels and patient outcome [55].”
BackgroundAnthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort
Roswall, N., Freisling, H., Bueno-de-Mesquita, H. B., Ros, M. M., Christensen, J., Overvad, K., Boutron‐Ruault, M., Severi, G., Fagherazzi, G., Chang-Claude, J. C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28936 · Cited by 35 · cited 1×
“and bladder cancers [14, 17].”
The Relation between Visceral Fat Measurement and Torso Level—Is One Level Better Than Another?
Warren, M., Schreiner, P. J., & Terry, J. G. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj049 · Cited by 25 · cited 1×
“Thus, there are suggestions that visceral fat should be derived by obtaining measurements at several different anatomic levels [54] although others have found no significant clinical impact when correlating visceral fat measured at L2L3, L4-L5 and mid waist levels and patient outcome [55].”
Background
Cited by
Sarcopenia – Molecular mechanisms and open questions
Wiedmer, P., Jung, T., Castro, J. P., Pomatto, L. C. D., Sun, P. Y., Davies, K. J. A., & Grune, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101200 · Cited by 471
Recent Issues on Body Composition Imaging for Sarcopenia Evaluation
Lee, K., Shin, Y., Huh, J., Sung, Y. S., Lee, I.-S., Yoon, K.-H., & Kim, K. W. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0479 · Cited by 336
Martin, L., Hopkins, J., Malietzis, G., Jenkins, J. T., Sawyer, M. B., Brisebois, R., MacLean, A., Nelson, G., Gramlich, L., & Baracos, V. E. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6652-x · Cited by 139
Currow, D. C., Maddocks, M., Cella, D., & Muscaritoli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113471 · Cited by 27
“An assessment approach that considers body composition is important for patients with lung cancer and cachexia, as neither body weight [46,47] nor BMI [48] are strongly correlated with LBM or skeletal muscle.”
BackgroundSong, G., Wang, L., Tang, J., Li, H., Pang, S., Li, Y., Liu, L., & Hu, J. (2023) · Metabolomics · doi:10.1007/s11306-023-02002-0 · Cited by 25
Metadata
- Authors
- Yip, C., Dinkel, C., Mahajan, A., Siddique, M., Cook, G. J. R., & Goh, V.
- Venue
- Insights into Imaging
- Published
- 2015-06-13
- Volume
- 6
- Issue
- 4
- Pages
- 489-497
- ISSN
- 1869-4101 (ISSN-L)
- OpenAlex
- W646091635
- Cited by
- 230
- References
- 75
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.